Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Centerra Gold Announces TSX Acceptance of Renewed Normal Course Issuer Bid
-
Bioventus Reports Third Quarter Financial Results
-
Hillman Reports Third Quarter 2024 Results
-
First Trust Introduces a Small and Mid Cap Dividend Achievers Target Income ETF
-
Repligen Corporation to Present at Upcoming Investor Conferences
-
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference
-
Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024
-
Streamline Health® Announces New eValuator™ Contract With Texas-Based Health System
-
BridgeBio Announces Publication of Case Study Exploring Portfolio Theory’s Impact on Biomedical Innovation in The Journal of Portfolio Management
-
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
-
DeFi Technologies Subsidiary Valour Introduces World’s first Physical Yield Bearing Bitcoin (1VBS) ETP in Collaboration with Core Foundation, to German Investors on Xetra, Offering Exposure to Bitco
-
Purpose Investments Unveils New Meta and AMD Single-Stock Yield Shares ETFs in Its Acclaimed Yield Shares Suite
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
MIND CTI Reports Third Quarter 2024 Results
-
A New Era in DeFi: OptSwap Launches Innovative Crypto Options Trading Platform
-
HUB Security Announces Strategic Initiatives and Upcoming Financial Results Amid U.S. Market Penetration Plans
-
GRASS, a DePIN Project, Will Be Initially Listed on CoinW Exchange
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
-
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
TransAlta Reports Strong Third Quarter 2024 Results
-
Xometry Reports Third Quarter 2024 Results
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Gate.io Shatters Records in Total Trading Volume in Q3 2024, with Its User Base Surpassing 17 Million
-
SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
-
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
-
Colliers Reports Third Quarter Results
-
Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results
-
Aura Minerals and Bluestone Resources Agree to Amendment to Arrangement Agreement
-
R1 RCM Reports Third Quarter 2024 Results
-
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
-
Beasley Broadcast Group Reports Third Quarter Revenue of $58.2 Million
-
NeuroMetrix Reports Q3 2024 Business Highlights
-
U.S. Energy Corp. Announces Third Quarter 2024 Results Conference Call Date
-
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
-
DLH to Provide Critical Systems Engineering and Integrated Logistics Services for Navy C5ISR Systems
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
-
Limitless X Announces Change of Ticker Symbol to LIMX on the OTCQB Exchange
-
Agrify Secures Financing from Green Thumb Industries and Announces New Leadership
-
LGI Homes Reports Third Quarter 2024 Results and Updates Full Year 2024 Guidance
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
-
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
-
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
-
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
-
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
-
ScottsMiracle-Gro Appoints Rob Candelino to Board of Directors
